Am J Psychiatry 155:1310-1318, October 1998
©Copyright 1998 American Psychiatric Association
Age-Associated Testosterone Decline in Men: Clinical Issues for Psychiatry
Harvey Sternbach, M.D.
Objective:The author summarizes current knowledge about the diagnosis and treatment of testosterone decline in healthy aging men and the associated clinical issues for psychiatry. Method:A MEDLINE search was conducted in which the search terms "male climacteric," "male menopause," "andropause," "viropause," "low-testosterone syndrome," and "testosterone replacement therapy" were used. Literature published before 1966 was identified by reviewing the reference lists of later publications.Results:Manifestations of testosterone deficiency have included depression, anxiety, irritability, insomnia, weakness, diminished libido, impotence, poor memory, reduced muscle and bone mass, and diminished sexual body hair. Although testosterone levels decline with age, there is great interindividual variability, and the connection between serum testosterone levels and clinical psychiatric signs and symptoms is not clear-cut, since other hormonal changes are implicated as well. Testosterone replacement therapy may offer hypogonadal men benefit, but long-term studies on its efficacy and safety are lacking. Comprehensive biopsychosocial assessment should be a routine part of the evaluation of complaints of low-testosterone syndrome in men.Conclusions:Testosterone decline/deficiency is not a state strictly analogous to female menopause and may exhibit considerable overlap with primary and other secondary psychiatric disorders. Am J Psychiatry 1998; 155: 1310-1318
This article has been cited by other articles:
|
|
|
|
 
A. Lacombe, V. Lelievre, C. E. Roselli, W. Salameh, Y.-h. Lue, G. Lawson, J.-M. Muller, J. A. Waschek, and E. Vilain
Delayed testicular aging in pituitary adenylate cyclase-activating peptide (PACAP) null mice
PNAS,
March 7, 2006;
103(10):
3793 - 3798.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. M. Ullrich, S. K. Lutgendorf, J. Leserman, D. G. Turesky, and K. J. Kreder
Stress, Hostility, and Disease Parameters of Benign Prostatic Hyperplasia
Psychosom Med,
May 1, 2005;
67(3):
476 - 482.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. E. Weinberger, S. Sreenivasan, T. Garrick, and H. Osran
The Impact of Surgical Castration on Sexual Recidivism Risk Among Sexually Violent Predatory Offenders
J Am Acad Psychiatry Law,
March 1, 2005;
33(1):
16 - 36.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. M. Shores, K. L. Sloan, A. M. Matsumoto, V. M. Moceri, B. Felker, and D. R. Kivlahan
Increased Incidence of Diagnosed Depressive Illness in Hypogonadal Older Men
Arch Gen Psychiatry,
February 1, 2004;
61(2):
162 - 167.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Xiao, Q. Zhang, F. Jiang, M. Pins, J. M. Kozlowski, and Z. Wang
Suppression of Prostate Tumor Growth by U19, a Novel Testosterone-regulated Apoptosis Inducer
Cancer Res.,
August 1, 2003;
63(15):
4698 - 4704.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Tengstrand, K. Carlstrom, and I. Hafstrom
Bioavailable testosterone in men with rheumatoid arthritis--high frequency of hypogonadism
Rheumatology,
March 1, 2002;
41(3):
285 - 289.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. R. Kandeel, V. K. T. Koussa, and R. S. Swerdloff
Male Sexual Function and Its Disorders: Physiology, Pathophysiology, Clinical Investigation, and Treatment
Endocr. Rev.,
June 1, 2001;
22(3):
342 - 388.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. P. M. Kruijver, A. Fernández-Guasti, M. Fodor, E. M. Kraan, and D. F. Swaab
Sex Differences in Androgen Receptors of the Human Mamillary Bodies Are Related to Endocrine Status Rather Than to Sexual Orientation or Transsexuality
J. Clin. Endocrinol. Metab.,
February 1, 2001;
86(2):
818 - 827.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
H. C. Margolese
The Male Menopause and Mood: Testosterone Decline and Depression in the Aging Male--Is There a Link?
J Geriatr Psychiatry Neurol,
July 1, 2000;
13(2):
93 - 101.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. K. Gouras, H. Xu, R. S. Gross, J. P. Greenfield, B. Hai, R. Wang, and P. Greengard
Testosterone reduces neuronal secretion of Alzheimer's beta -amyloid peptides
PNAS,
February 1, 2000;
97(3):
1202 - 1205.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. G. Rabkin, G. J. Wagner, and R. Rabkin
A Double-blind, Placebo-Controlled Trial of Testosterone Therapy for HIV-Positive Men With Hypogonadal Symptoms
Arch Gen Psychiatry,
February 1, 2000;
57(2):
141 - 147.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Chen and B. R. Zirkin
Long-term suppression of Leydig cell steroidogenesis prevents Leydig cell aging
PNAS,
December 21, 1999;
96(26):
14877 - 14881.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. T. Prehn
On the Prevention and Therapy of Prostate Cancer by Androgen Administration
Cancer Res.,
September 1, 1999;
59(17):
4161 - 4164.
[Abstract]
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 1998
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
